Quick Takeaways
- Point72 Asset Management, L.P. filed SCHEDULE 13G for Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share (DYN).
- Disclosed ownership: 5.1%.
- Date of event: 31 Jan 2025.
Point72 Asset Management, L.P. - 31 Jan 2025 SCHEDULE 13G Report for Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share (DYN)
- Filing Manager
- Point72 Asset Management, L.P.
- Reporting Manager
- Point72 Asset Management, L.P.
- Symbol
- DYN
- Shares outstanding
- 101,894,059 shares
- Disclosed Ownership
- 5,196,597 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 03 Feb 2025, 17:07:22 UTC
- Date of event
- 31 Jan 2025
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Point72 Asset Management, L.P. disclosed 5.1% ownership in Dyne Therapeutics, Inc. Common Stock, par value $0.0001 per share (DYN) on 31 Jan 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Feb 2025, 17:07.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Point72 Asset Management, L.P. | 5.1% | 5,196,597 | 0 | 5,196,597 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Point72 Capital Advisors, Inc. | 5.1% | 5,196,597 | 0 | 5,196,597 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person | |
| Steven A. Cohen | 5.1% | 5,196,597 | 0 | 5,196,597 | /s/ Jason M. Colombo | Jason M. Colombo, Authorized Person |